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background:  Patients with end-stage liver disease (ESLD) may develop left ventricular diastolic dysfunction in the absence of coronary artery 
disease or hypertension. Prognostic value of the presence of diastolic dysfunction on post orthotopic liver transplant (OLT) survival is unknown. We 
report on the association of diastolic dysfunction and 2-year mortality after OLT in patients with ESLD.
Methods:  Demographic and clinical variables of 574 patients with ESLD who underwent OLT between 2000 and 2011 were reviewed. 
Echocardiographic data were obtained at the time of standard cardiovascular evaluation before OLT. Mortality data were obtained from hospital 
charts and social security death index.
results:  Data on 397 males (mean age 51±10 years) and 173 females (mean age 56±11 years) with ESLD were analyzed. Mean LV ejection 
fraction (LVEF) was 69±8%. Mean estimated pulmonary artery systolic pressure (PASP) was 32±8 mmHg. Hundred and eight patients (19%) were 
diagnosed with grade one diastolic dysfunction based on transthoracic echocardiography. Thirty seven percent of patients had left ventricular 
hypertrophy (LVH) and hypertension in 40% of patients with diastolic dysfunction. History of hypertension and diastolic dysfunction, not the gender 
and LVH were independent predictors of 2-year mortality after OLT (hypertension: OR=3.6, 95% CI=1.4-9.4, p=0.008; diastolic dysfunction: OR=2.7, 
95% CI=1.1-6.4, p=0.025).
conclusions:  Left ventricular diastolic dysfunction is independently associated with long-term mortality after liver transplantation. The cause 
of diastolic dysfunction in this patient population is unclear as prevalence of hypertension and LVH is low. Presence of diastolic dysfunction may 
provide additional insight in cardiovascular risk assessment before OLT in patients with end stage liver disease.
